In contrast, conditional knockdown of neuronal CCR5 prior to stroke or pharmacological antagonism of CCR5 1 day after the stroke incident were shown to be beneficial for the neurological outcome and enhanced brain plasticity (Joy et al., 2019). This evidence concerns the gene CCR5 and stroke disorder.